International Council for Commonality in Blood Banking Automation, Inc.

Disclaimer:
Information regarding a non-State actor, contained in the section “Non-State Actors Profiles” in the Register, has been provided by that non-State actor itself, and the accuracy and completeness of such information is the sole responsibility of that non-State actor, not WHO. In turn, information in the sections “WHO’s Engagement” and “Non-State Actors in Official Relations” has been provided by WHO, subject to certain conditions. All access and use of any section of the Register is governed by the Terms and Conditions of Use.

 Overview

International Council for Commonality in Blood Banking Automation, Inc.
ICCBBA
ICCBBA is the international standards organization responsible for the management and development of the ISBT 128 Standard for blood and transplant. The ISBT 128 standard has been designed to ensure the highest levels of accuracy, safety, and efficiency for the benefit of donors and patients worldwide. ISBT 128 provides international consistency to support the transfer, traceability and transfusion/transplantation of blood, cells, tissues and organs.

ICCBBA's vision: Global adoption of ISBT 128 for all medical products of human origin (MPHO).

ICCBBA's mission: Enhancing patient safety by promoting and managing the ISBT 128 international information standard for use with medical products of human origin.

ICCBBA's priorities:
-To manage international information standards for transfusion medicine, transplantation, and other applications of medical products of human origin in support of traceability, biovigilance, and patient safety.
-To liaise with health authorities, regulators, scientific and professional societies, user communities, and vendors on standardization in terminology and information technology.
-To provide educational programs to promote the value of, and need for, information standards and policies to support traceability and biovigilance.
-To provide technical consultation regarding the implementation and management of ISBT 128.
-To lead in the continued development of common data structures for information technology, data processing, exchange and transfer, and labeling for medical products of human origin.
www.isbt128.org
17 Oct 2022 10:56:39 PM

 General information

International Council for Commonality in Blood Banking Automation, Inc.
ICCBBA
ICCBBA
International Council for Commonality in Blood Bank Automation Inc
ICCBBA
ICCBBA is the international standards organization responsible for the management and development of the ISBT 128 Standard for blood and transplant. The ISBT 128 standard has been designed to ensure the highest levels of accuracy, safety, and efficiency for the benefit of donors and patients worldwide. ISBT 128 provides international consistency to support the transfer, traceability and transfusion/transplantation of blood, cells, tissues and organs.

ICCBBA's vision: Global adoption of ISBT 128 for all medical products of human origin (MPHO).

ICCBBA's mission: Enhancing patient safety by promoting and managing the ISBT 128 international information standard for use with medical products of human origin.

ICCBBA's priorities:
-To manage international information standards for transfusion medicine, transplantation, and other applications of medical products of human origin in support of traceability, biovigilance, and patient safety.
-To liaise with health authorities, regulators, scientific and professional societies, user communities, and vendors on standardization in terminology and information technology.
-To provide educational programs to promote the value of, and need for, information standards and policies to support traceability and biovigilance.
-To provide technical consultation regarding the implementation and management of ISBT 128.
-To lead in the continued development of common data structures for information technology, data processing, exchange and transfer, and labeling for medical products of human origin.
PO Box 11309
San Bernardino
CA
92423-1309
United States of America
support@isbt128.org
www.isbt128.org

 Governance

Virginia Non-stock Corporation
1995
Board of Directors
Diane Wilson
Treasurer
Community Tissue Services
Prof. Dr. Martin Hildebrandt
Member
TUMCells
Joy Mammen
Member
Christian Medical College Vellore, India
Timothy L. Pruett, MD
Chair
University of Minnesota
Zbigniew M Szczepiorkowski, MP, PhD, FCAP
Vice-Chair
Dartmouth-Hitchcock Medical Center,
Kelly Tilleman, PhD, MSc
Secretary
Ghent University Hospital
Matthew Kuehnert
Member
US Centers for Disease Control and Prevention
Mohammed Farouk
Member
Africa Society for Blood Transfusion
Mickey B C Koh
Member
St. George's Hospital
Diego Ponzin
Member
Veneto Eye Bank Foundation
Govern the implementation of the ICCBBA mission;
Develop of the ICCBBA strategic plan;
Approve the business plan developed by the Executive Director;
Approve the budget and fee proposals;
Ensure compliance with all regulatory agencies;
Ensure legal and ethical integrity;
Hold fiduciary responsibility for the organization

 Financial information

January
2021
December
2021
2,220,181
December
2021
2,441,714
Private sector entities (including business associations)
Philanthropic foundations
NGOs, academic institutions
Government entities, intergovernmental organizations, including UN
General public, individuals
Total
2,010,160
2,010,160
210,021
210,021
2,220,181
2,220,181

 Membership

Individuals
NGOs
Private sector entities
Philanthropic foundations
Academic institutions
Government entities
Intergovernmental organizations

Organizational Structure

No data available
No data available

Relations

No data available
No data available

  Activities

ICCBBA was established as a self-funded, international, not-for-profit standards organization to:
(a) be organized and operated exclusively for charitable, scientific and educational purposes
(b) support the development, updating, maintenance and promotion of (i) international standards for labeling, data structures and associated code tables for transfusion and transplantation, (ii) related electronic data interchange protocols, and to provide a central focus for information transfer, code assignments and distribution, and technical expertise regarding transfusion and transplantation automation, and (iii) educational materials, programs and policies designed to educate the transfusion and transplantation community particularly, and the public generally, regarding the foregoing purposes and the efforts of ICCBBA in achieving those purposes.
Strategic Priority 1: One billion more people benefiting from universal health coverage
Strategic Priority 2: One billion more people better protected from health emergencies
Strategic Priority 3: One billion more people enjoying better health and well-being
Strategic Priority 4: More effective and efficient WHO providing better support to countries

  Country presence

Regions
Countries
Activities
Members
Offices / representatives
African Region
Region of the Americas
Eastern Mediterranean Region
European Region
South-East Asia Region
Western Pacific Region
Global

  Disclosure & declaration

Pursuant the WHO Framework of Engagement with Non-State Actors, WHO does not engage with the tobacco industry or non-State actors that work to further the interests of the tobacco industry. WHO also does not engage with the arms industry.

For the purposes of this statement:

  • tobacco industry means any entity involved in the manufacture, sale or distribution of tobacco and related products, and any affiliate of such entity; and
  • arms industry means any entity involved in the manufacture, sale or distribution of arms, and any affiliate of such entity.

This disclosure statement needs to be provided by any nongovernmental organization, private sector entity, philanthropic foundation and academic institution prior to engaging with WHO.

In view of the foregoing, please answer the following questions:

  1. Is your entity, or was your entity over the last four years, part of the tobacco or arms industries (as defined above)?
  1. To the best of your entity’s knowledge, is your entity, or has your entity over the last four years, engaged in activities that are aimed at furthering or supporting the interests of the tobacco industry? This includes, but is not limited to, supply contracts, contract work, services and lobbying.
  1. To the best of your entity’s knowledge, does your entity currently, or did your entity over the last four years, have any other association or relationship with the tobacco industry (as defined above). This includes in particular investment interests (other than general mutual funds or similar arrangements whereby your entity has no control over the selection of the investments), commercial business interests, the provision or receipt of financial and/or other support.
  1. If you have answered yes to any of the above or are unable to answer one or more questions, please provide a general statement of explanation.

Please note that the WHO Secretariat reserves the right to request additional information from your entity in this regard.
By providing this statement, your entity commits to promptly inform WHO of any change to the above information and to complete a new statement that describes the changes.
The ISBT 128 Standard is used by healthcare facilities to ensure globally unique identification of MPHO. ICCBBA licenses healthcare facilities to use the ISBT 128 Standard.